These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17384012)

  • 61. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
    Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
    Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio.
    Jensen J; Ma LP; Fu ML; Svaninger D; Lundberg PA; Hammarsten O
    Clin Res Cardiol; 2010 Jul; 99(7):445-52. PubMed ID: 20229122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides.
    Saenger AK; Rodriguez-Fraga O; Ler R; Ordonez-Llanos J; Jaffe AS; Goetze JP; Apple FS
    Clin Chem; 2017 Jan; 63(1):351-358. PubMed ID: 28062628
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides.
    Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C
    Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples.
    Mueller T; Gegenhuber A; Dieplinger B; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2004; 42(8):942-4. PubMed ID: 15387447
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Measurement Nt-proBNP circulating concentrations in heart failure patients with a new point-of-care assay.
    Lepoutre T; Rousseau MF; Ahn SA; Gruson D
    Clin Lab; 2013; 59(7-8):831-5. PubMed ID: 24133913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.
    Rosenberg J; Gustafsson F; Remme WJ; Riegger GA; Hildebrandt PR
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):305-11. PubMed ID: 18309461
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.
    Nishikimi T; Ikeda M; Takeda Y; Ishimitsu T; Shibasaki I; Fukuda H; Kinoshita H; Nakagawa Y; Kuwahara K; Nakao K
    Heart; 2012 Jan; 98(2):152-61. PubMed ID: 21719557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anemia considerations when assessing natriuretic peptide levels in ED patients.
    Karakoyun I; Colak A; Arslan FD; Hasturk AG; Duman C
    Am J Emerg Med; 2017 Nov; 35(11):1677-1681. PubMed ID: 28587950
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.
    McKelvie RS; Komajda M; McMurray J; Zile M; Ptaszynska A; Donovan M; Carson P; Massie BM;
    J Card Fail; 2010 Feb; 16(2):128-34. PubMed ID: 20142024
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
    Liang F; O'Rear J; Schellenberger U; Tai L; Lasecki M; Schreiner GF; Apple FS; Maisel AS; Pollitt NS; Protter AA
    J Am Coll Cardiol; 2007 Mar; 49(10):1071-8. PubMed ID: 17349887
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.